Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 78 out of 100. Clinical trials

Topic: Brain imaging, connectivity and assessment

Introduction Mild Cognitive Impairment (MCI) is defined as a decline in one or more cognitive domains worse than expected for age and encompasses several subtypes depending on the cognitive(s) function(s) impaired. Older adults presenting amnestic MCI combined with one or several other impaired domains are the highest at risk of dementia. Yet, no consensual screening method for MCI in community-dwelling older adults has been established. The aim of this study was to identify cognitive aging profiles using multivariate analysis based on three neuropsychological assessments and to characterize profiles consistent with different probable MCI subtypes. Methods A total of 161 community-dwelling older adults from the 13EVAL cluster-randomized controlled trial performed the Montreal Cognitive Assessment including the Memory Index Score, the Trail Making Test and the Victoria Stroop Test. Hierarchical clustering on principal components was conducted based on four cognitive domains (global cognition, memory, inhibition and cognitive flexibility) and age. Inter-groups comparisons were performed using one-way ANOVA. Individual performances were compared to normative standard for each assessment to characterize each group. Results Three clusters were identified that differed significantly in age ( F 2,158 =78.56, p <.001, η 2 p =.50), global cognition ( F 2,158 =96.07, p <.001, η 2 p =.55), memory ( F 2,158 =81.48, p <.001, η 2 p =.51), cognitive flexibility ( F 2,158 =52.25, p <.001, η 2 p =.40) and inhibition ( F 2,158 =12.14, p <.001, η 2 p =.13). Inter-groups comparisons and comparisons to normative values led to the characterization of Cluster 1 as normal cognition, Cluster 2 as probable executive MCI and Cluster 3 as probable amnestic and executive MCI. Conclusions Individuals with cognitive profiles consistent with probable executive MCI were identified using simple assessments of global cognition, memory and executive functions in a community-dwelling older population. As participants were not clinically diagnosed, further prospective studies are needed to determine the screening performance of this approach.

Key findings

Study details

How this study scored 78/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 11 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 1 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 0 of 2. 45 of the 58 points it could be judged on, which is 78 of 100. Total 78 of 100.45 of the 58 points we could judge = 78 of 100

Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for effect reported because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 45 of the 58 points we could judge it on, which is 78 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in aging neuroscience)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 11 / 12 A randomised controlled trial
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 161 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 1 / 2 Randomised (as stated in the record)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 45 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 45 of the 58 points we could judge it on is 78 out of 100.
Total 78 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Mauti, R., Chouk, C., Guillot, A., Peronin, A., Fargier, P., & Chabaud, P. (2026). A clustering approach based on neuropsychological testing to detect early signs of probable MCI among community-dwelling older adults. Frontiers in aging neuroscience. https://doi.org/10.64898/2026.07.04.26357270

Vancouver

Mauti R, Chouk C, Guillot A, Peronin A, Fargier P, Chabaud P. A clustering approach based on neuropsychological testing to detect early signs of probable MCI among community-dwelling older adults. Frontiers in aging neuroscience. 2026. doi:10.64898/2026.07.04.26357270.

BibTeX

@article{mauti2026-183d3fda,
  author  = {Mauti, R. and Chouk, C. and Guillot, A. and Peronin, A. and Fargier, P. and Chabaud, P.},
  title   = {{A clustering approach based on neuropsychological testing to detect early signs of probable MCI among community-dwelling older adults}},
  journal = {Frontiers in aging neuroscience},
  year    = {2026},
  doi     = {10.64898/2026.07.04.26357270},
  url     = {https://doi.org/10.64898/2026.07.04.26357270}
}

Related studies in Clinical trials

Similar studies

More on Clinical trials

See all studies in Clinical trials →